Royce & Associates LP Increases Holdings in Select Medical Holdings Corporation $SEM

Royce & Associates LP lifted its position in Select Medical Holdings Corporation (NYSE:SEM) by 12.1% in the 4th quarter, HoldingsChannel reports. The firm owned 492,505 shares of the health services provider’s stock after purchasing an additional 53,000 shares during the quarter. Royce & Associates LP’s holdings in Select Medical were worth $7,314,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently modified their holdings of the company. 8 Knots Management LLC purchased a new position in shares of Select Medical during the 2nd quarter valued at about $26,568,000. Millennium Management LLC raised its stake in shares of Select Medical by 407.9% during the 3rd quarter. Millennium Management LLC now owns 1,590,339 shares of the health services provider’s stock valued at $20,420,000 after buying an additional 1,277,233 shares during the last quarter. Western Standard LLC purchased a new stake in Select Medical in the 3rd quarter worth approximately $13,551,000. Qube Research & Technologies Ltd purchased a new stake in Select Medical in the 3rd quarter worth approximately $7,401,000. Finally, Woodline Partners LP purchased a new stake in Select Medical in the 3rd quarter worth approximately $7,159,000. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Price Performance

Shares of Select Medical stock opened at $16.51 on Friday. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.88. Select Medical Holdings Corporation has a twelve month low of $11.65 and a twelve month high of $16.99. The business has a 50-day moving average price of $16.41 and a 200 day moving average price of $15.58. The firm has a market cap of $2.05 billion, a PE ratio of 15.57, a P/E/G ratio of 0.95 and a beta of 1.02.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.07). Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The business had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.41 billion. During the same quarter in the prior year, the firm earned $0.44 EPS. Select Medical’s revenue for the quarter was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Sell-side analysts predict that Select Medical Holdings Corporation will post 1.26 earnings per share for the current fiscal year.

Select Medical announced that its board has approved a stock buyback program on Thursday, February 19th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the health services provider to repurchase up to 49.5% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s management believes its shares are undervalued.

Select Medical Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were paid a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s payout ratio is 23.58%.

Analysts Set New Price Targets

SEM has been the topic of several recent research reports. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Mizuho restated a “neutral” rating and issued a $16.50 price objective (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Royal Bank Of Canada restated a “sector perform” rating and issued a $16.50 price objective (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Finally, Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. One equities research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $15.50.

Select Medical Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.